Abivax
company in Paris, France
ISIN FR0012333284 LEI 969500D8TMNB184OJU95
Follow Abivax
Weekly email: filings, results
Net income
−€336.1M
−90.7% vs prior year
EPS, diluted
−€4.83
−72.5% vs prior year
Operating cash flow
−€161.1M
−4.6% vs prior year
Operating income
−€246.1M
−42.2% vs prior year
Source: ESEF annual reports · latest filing
Show the numbers
| Year | Net income |
|---|---|
| FY25 | −€336.1M |
| FY24 | −€176.2M |
| FY23 | −€147.7M |
| FY22 | −€60.7M |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −€161.3M |
| FY24 | −€154.7M |
| FY23 | −€97.4M |
| FY22 | −€54.2M |